[Influenceability of lung ventilation capacity in bronchospastic conditions].
D001249:Asthma / Q000628:therapy*; D001286:Atropine Derivatives; D001991:Bronchitis / Q000628:therapy*; D006801:Humans; D008176:Lung Volume Measurements; D010208:Papaverine / Q000627:therapeutic use*; D010634:Phenobarbital / Q000627:therapeutic use*; D012119:Respiration; D013806:Theophylline / Q000031:analogs & derivatives; D014691:Ventilation
D001286:Atropine Derivatives; D013806:Theophylline; D010208:Papaverine; D010634:Phenobarbital
ASTHMA/therapy; ATROPINE/related compounds; BRONCHITIS/therapy; PAPAVERINE/therapeutic use; PHENOBARBITAL/therapeutic use; THEOPHYLLINE/related compounds
Beitrag zur Beeinflussbarkeit der ventilatorischen Lungenleistung bei bronchospastischen Zuständen.